231 related articles for article (PubMed ID: 31339046)
1. Role of
Ming XL; Feng YL; He DD; Luo CL; Rong JL; Zhang WW; Ye P; Chai HY; Liang CZ; Tu JC
Epigenomics; 2019 Aug; 11(10):1209-1231. PubMed ID: 31339046
[No Abstract] [Full Text] [Related]
2. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract][Full Text] [Related]
3. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
4. Identification of aberrantly expressed lncRNA and the associated TF-mRNA network in hepatocellular carcinoma.
Wang B; Tang D; Zhang Z; Wang Z
J Cell Biochem; 2020 Feb; 121(2):1491-1503. PubMed ID: 31498488
[TBL] [Abstract][Full Text] [Related]
5. Clinical value and potential mechanisms of
Feng Y; Dramani Maman ST; Zhu X; Liu X; Bongolo CC; Liang C; Tu J
Epigenomics; 2021 Feb; 13(4):299-317. PubMed ID: 33406920
[No Abstract] [Full Text] [Related]
6. Construction of a long non-coding RNA-associated ceRNA network reveals potential prognostic lncRNA biomarkers in hepatocellular carcinoma.
Yan Y; Yu J; Liu H; Guo S; Zhang Y; Ye Y; Xu L; Ming L
Pathol Res Pract; 2018 Dec; 214(12):2031-2038. PubMed ID: 30316688
[TBL] [Abstract][Full Text] [Related]
7. Analysis of competing endogenous RNA network identifies a poorly differentiated cancer-specific RNA signature for hepatocellular carcinoma.
Chen QF; Huang T; Si-Tu QJ; Wu P; Shen L; Li W; Huang Z
J Cell Biochem; 2020 Mar; 121(3):2303-2317. PubMed ID: 31642123
[TBL] [Abstract][Full Text] [Related]
8. Identification of a long non‑coding RNA‑mediated competitive endogenous RNA network in hepatocellular carcinoma.
He H; Chen D; Cui S; Piao H; Tang H; Wang X; Ye P; Jin S
Oncol Rep; 2019 Aug; 42(2):745-752. PubMed ID: 31173261
[TBL] [Abstract][Full Text] [Related]
9. The competitive endogenous RNA regulatory network reveals potential prognostic biomarkers for overall survival in hepatocellular carcinoma.
Zhang Z; Li J; He T; Ouyang Y; Huang Y; Liu Q; Wang P; Ding J
Cancer Sci; 2019 Sep; 110(9):2905-2923. PubMed ID: 31335995
[TBL] [Abstract][Full Text] [Related]
10. The mRNA-miRNA-lncRNA Regulatory Network and Factors Associated with Prognosis Prediction of Hepatocellular Carcinoma.
Hu B; Ma X; Fu P; Sun Q; Tang W; Sun H; Yang Z; Yu M; Zhou J; Fan J; Xu Y
Genomics Proteomics Bioinformatics; 2021 Dec; 19(6):913-925. PubMed ID: 33741523
[TBL] [Abstract][Full Text] [Related]
11. Identification of Potential Diagnostic and Prognostic Pseudogenes in Hepatocellular Carcinoma Based on Pseudogene-miRNA-mRNA Competitive Network.
Yan L; Yue C; Xu Y; Jiang X; Zhang L; Wu J
Med Sci Monit; 2020 May; 26():e921895. PubMed ID: 32457285
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
13. Integrated Analysis of an lncRNA-Associated ceRNA Network Reveals Potential Biomarkers for Hepatocellular Carcinoma.
Yang J; Xu QC; Wang ZY; Lu X; Pan LK; Wu J; Wang C
J Comput Biol; 2021 Mar; 28(3):330-344. PubMed ID: 33185458
[No Abstract] [Full Text] [Related]
14. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
15. A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma.
Tang J; Zhuo H; Zhang X; Jiang R; Ji J; Deng L; Qian X; Zhang F; Sun B
Cell Death Dis; 2014 Dec; 5(12):e1549. PubMed ID: 25476897
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
19. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
20. Candidate lncRNA-miRNA-mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis.
Zhang R; Jiang YY; Xiao K; Huang XQ; Wang J; Chen SY
J Cancer Res Clin Oncol; 2020 Jan; 146(1):87-96. PubMed ID: 31758243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
